Sign up to save your podcasts
Or
Share Brenntag Pharma: Adding Value and Reducing Distribution Complexity
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Brenntag Pharma: Adding Value and Reducing Distribution Complexity
Brenntag Pharma is a leading distribution partner in the pharmaceutical, veterinary and healthcare industries, offers over 10,000 products for the formulation of pharmaceuticals and the chemical synthesis of Active Pharmaceutical Ingredients.
"We are the bridge between the manufacturers of raw materials and ingredients to those that produce medicines. We develop partnerships with all types of companies from big pharma to startups" says Catarina Gil Forte, Head of Industry for Synthesis & Biopharma at Brenntag Pharma.
More than just manage the logistics and warehousing, Catarina explains that Brenntag aims to simplify the complexities of pharma and biopharma supply chain operations with a range of value-added services.
These services include:
Distribution strategies to manage working capital
Reflecting on the current economic environment, Catarina notes that due to inflation some customers are struggling with getting the right balance of stock-levels.
"Working capital is an important topic at the moment and distribution can play an important role here. We can support our customers on defining their forecasts and ensuring that they receive the product on time, and do not overstock their warehouse."
"There is a big responsibility with our product managers to get the right balance between the products that we have in stock, and those that need to be supplied on time. We also support customers in managing costs by working with the best partners from supplier-side."
Read the full article on PharmaSource
View all episodes
By Life Science NetworksBrenntag Pharma is a leading distribution partner in the pharmaceutical, veterinary and healthcare industries, offers over 10,000 products for the formulation of pharmaceuticals and the chemical synthesis of Active Pharmaceutical Ingredients.
"We are the bridge between the manufacturers of raw materials and ingredients to those that produce medicines. We develop partnerships with all types of companies from big pharma to startups" says Catarina Gil Forte, Head of Industry for Synthesis & Biopharma at Brenntag Pharma.
More than just manage the logistics and warehousing, Catarina explains that Brenntag aims to simplify the complexities of pharma and biopharma supply chain operations with a range of value-added services.
These services include:
Distribution strategies to manage working capital
Reflecting on the current economic environment, Catarina notes that due to inflation some customers are struggling with getting the right balance of stock-levels.
"Working capital is an important topic at the moment and distribution can play an important role here. We can support our customers on defining their forecasts and ensuring that they receive the product on time, and do not overstock their warehouse."
"There is a big responsibility with our product managers to get the right balance between the products that we have in stock, and those that need to be supplied on time. We also support customers in managing costs by working with the best partners from supplier-side."
Read the full article on PharmaSource